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TUBERKULOSIS KANAK-KANAK: PENILAIAN DAN DAPATAN 
KLINIKAL DAN PENETAPAN RAWATAN DI HOSPITAL-HOSPITAL 
SECARA MULTICENTER DI SINDH, PAKISTAN 
ABSTRAK 
Pakistan berada di kedudukan yang ke-11 dalam kalangan negara-negara yang 
mempunyai beban tuberkulosis (TB) yang tinggi di mana TB diberi nilai ke-6 dari 10 
penyebab mortaliti. Walaupun garis panduan Kebangsaan bagi diagnosis dan 
pengurusan TB dalam kalangan kanak-kanak telah ditubuhkan pada tahun 2007, 
sedikit yang diketahui mengenai hasil pengurusan dan rawatan TB bagi kanak-kanak 
di Pakistan. Bagi tujuan ini, kanak-kanak yang dirawat di bawah Kursus Pendek 
Rawatan Pemerhatian Secara Langsung (DOTS) di lima buah hospital multicenter di 
Sindh telah direkrut sebagai kohort dalam kajian pemerhatian ini. Sejumlah 2,167 
orang kanak- kanak telah didaftarkan semasa fasa retrospektif daripada tahun 2011 
sehingga 2015 dan bagi fasa prospektif daripada 1 Jun 2016 sehingga 30 November 
2016, 508 orang kanak-kanak telah didaftarkan dengan TB di tapak kajian. Semasa 
tempoh kajian, TB bagi kanak-kanak menyumbang sebanyak 12.2% daripada semua 
kes TB di daerah- daerah Hyderabad, Jamshoro dan Matiari. Dalam kajian ini, 12.1% 
adalah bakteria positif yang telah disahkan. Pada akhir fasa intensif, 79.3% pesakit 
mencapai penukaran lumuran dahak. Pesakit-pesakit yang mempunyai hubungan yang 
rapat dan yang berpengalaman dengan kesan-kesan yang buruk adalah dengan 
ketaranya berkemungkinan kurang untuk mendapat penukaran dahak dan lebih 
berkemungkinan menjadi positif dahak semasa rawatan. Sekitar 13.2% pesakit- 
pesakit mengalami kesan-advers yang buruk. Dalam analisis multivariat, kanak-kanak 
perempuan yang mendapat rawatan terdahulu dan yang tidak mempunyai parut BCG 
xx 
adalah berisiko tinggi untuk mengalami kesan advers ubat anti-TB. Kadar kejayaan 
rawatan keseluruhan telah direkodkan sebanyak 93%. Penduduk-penduduk luar 
bandar, positif lumuran dahak, kanak-kanak dengan rawatan sebelumnya, mereka yang 
mempunyai ADR dan hubungan isi rumah dengan TB telah muncul sebagai peramal-
peramal bagi hasil rawatan yang tidak berjaya. Sehingga kini, penyelidikan untuk 
pematuhan terhadap rawatan TB dalam kalangan kanak-kanak adalah terhad. Bagi 
tujuan ini, pematuhan telah diukur menggunakan Skala Analog Visual (VAS) dan 
Skala Pematuhan Perubatan Morisky Green Levine (MGLS). Pematuhan rawatan 
dalam kalangan penjaga-penjaga dalam kajian ini telah direkodkan sebanyak 86% ke 
atas MGLS dan 90.7% dengan VAS. Analisis komponen utama dalam kajian semasa 
telah menunjukkan bahawa MGLS yang telah diubahsuai adalah satu dimensi dan 4 
perkara-perkara telah dimuatkan dengan baik ke atas faktor tunggal. Hubungan VAS 
dengan MGLS-U adalah 0.572 yang menunjukkan persamaan yang baik antara kedua-
dua skor dan instrumen-instrumen telah dilaksanakan dengan baik dalam kalangan 
penjaga-penjaga dengan pendidikan yang lebih rendah. Penjaga-penjaga lelaki, 
mereka yang berumur ≥ 45 tahun, tanpa pendidikan formal, mempunyai kekangan 
kewangan, dilaporkan mempunyai kaunseling yang tidak mencukupi oleh pekerja-
pekerja penjagaan kesihatan serta doktor dan sikap tidak ambil peduli terhadap 
professional penjagaan kesihatan telah diperhatikan sebagai faktor penyumbang 
kepada ketidakpatuhan dalam kalangan penjaga-penjaga di tapak kajian. Kelaziman 
keseluruhan TB dalam kalangan hubungan isi rumah adalah 1.5%. Kanak-kanak yang 
mempunyai hubungan isi rumah dengan TB dan merokok telah diperhatikan dengan 
risiko yang lebih tinggi untuk membangunkan TB. Hanya 33.8% kanak-kanak yang 
diberi terapi pencegahan isoniazid (IPT) (26/77) dengan berjaya telah menyelesaikan 
kursus enam bulan tersebut. Sebagai kesimpulan, kadar 12.2% TB kanak-kanak yang 
 
xxi  
diberitahu dalam kajian semasa adalah membimbangkan. Faktor penting yang 
berkaitan dengan (P < 0.05) (isi rumah yang mempumyai kontek dengan TB dan 
mengalami kesan advers), kesan advers (wanita dan kanak-kanak dengan rawatan 
terdahulu), hasil rawatan yang tidak berjaya (Penduduk luar bandar, positif pundi 
pesakit, kanak-kanak dengan rawatan terdahulu, kenalan dengan TB), dan tidak 
mematuhinya (penjaga lelaki, mereka yang berumur ≥ 45 tahun, tanpa pendidikan 
formal, mempunyai masalah kewangan, melaporkan kaunseling yang tidak mencukupi 
oleh pekerja penjagaan kesihatan dan juga para doktor dan sikap tidak ambil peduli 
terhadap profesional penjagaan kesihatan) boleh dibuktikan secara praktikal sebelum 
atau tepat pada masa dalam rawatan. Kadar kejayaan rawatan adalah 
memberangsangkan tetapi dapat dipertingkatkan lagi dengan memberi perhatian yang 
















CHILDHOOD TUBERCULOSIS: EVALUATION OF CLINICAL 
OUTCOMES AND TREATMENT COMPLIANCE IN MULTICENTER 
HOSPITALS OF SINDH, PAKISTAN 
 
ABSTRACT 
Pakistan is ranked 11 among the high tuberculosis (TB) burden countries where 
TB is rated 6th of top 10 causes of mortality. Although, the national guidelines for the 
diagnosis and management of TB in children were established in 2007, but little is 
known about the management and treatment outcomes of childhood TB in Pakistan. 
For this purpose, children treated under Directly Observed Treatment Short course 
(DOTS) at (5) multicentre hospitals of Sindh were recruited as cohort in this 
observational study. Total 2,167 children were registered during retrospective phase 
from 2011 to 2015 and for prospective phase from 1st June 2016 to 30th November 
2016, 508 children were enrolled with TB at the study site. During the study period, 
childhood TB accounted 12.2% of all TB cases in Hyderabad, Jamshoro and Matiari 
districts. In the present study, 12.1% were bacteriologically confirmed sputum smear 
positive cases. At the end of intensive phase, 79.3% of patients achieved sputum smear 
conversion. Patients who had household contacts with TB and experienced adverse 
effects were significantly less likely to achieve sputum conversion and were more 
likely to become sputum positive during the treatment. Around 13.2% of patients came 
across with adverse effects. In multivariate analysis females and children with previous 
treatment were at greater risk to develop adverse effects due to anti-TB drugs. The 
overall treatment success rate was recorded as 93%. Rural residents, sputum smear 
positive, children with previous treatment, those who had ADRs and household 
contacts with TB emerged as predictors for unsuccessful treatment outcomes. 
Treatment adherence among the caregivers using Visual analog scale (VAS) and 
 
xxiii  
Morisky Green Levine Medication Adherence Scale (MGLS) in the present study was 
recorded as 86% on MGLS and 90.7% with VAS. The principal component analysis 
in the current study indicated that the modified MGLS was one-dimensional and the 4 
items loaded well onto the single factor. The correlation of VAS with MGLS-U was 
0.572 that demonstrates good association between the two scores and the instruments 
performed well in caregivers with lower education. Male caregivers, those aged ≥ 45 
years, with no formal education, had financial barrier, reported insufficient counselling 
by health care workers as well as clinicians and ignorant attitude of health care 
professional were observed as contributing factor to non-adherence among caregivers 
at the study site. The overall prevalence of TB among household contacts was 1.5%. 
Children who had household contacts with TB and smoking were observed at 
significantly higher risk for developing TB. Only 33.8% of children who were given 
isoniazid preventive therapy (IPT) (26/77) successfully completed the six-month 
course. In conclusion, the proportion of 12.2% childhood TB notified in the current 
study is alarming. The positively significant associated factors (P < 0.05) of sputum 
non-conversion (household contacts with TB and experienced adverse effects), 
adverse effects (females and children with previous treatment), unsuccessful treatment 
outcomes (Rural residents, sputum smear positive, children with previous treatment, 
those who had ADRs and household contacts with TB), and non-adherence (Male 
caregivers, those aged ≥ 45 years, with no formal education, had financial barrier, 
reported insufficient counselling by health care workers as well as clinicians and 
ignorant attitude of health care professional) are practically detectible before or timely 
in the course of treatment. The rate of treatment success was promising but can be 
further improved by giving significant attention and granting enhanced clinical 








Tuberculosis (TB) is expected to have affected humans for most of their history 
and remains a major reason of death worldwide regardless of the discovery of its 
effective and affordable therapy more than 50 years ago (Holloway et al., 2011). 
According to the World Health Organization (WHO) about one third of the global 
population is infected by Mycobacterium tuberculosis (MTB). 
In 2016, TB was one of the top 10 reasons of death at global level, ranking over 
Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 
(HIV/AIDS) as one of the foremost causes of death from an infectious disease. During 
same year, 10.4 million new TB cases were estimated worldwide which comprise 90% 
adults and 65% male (WHO, 2017). According to WHO reports, the continuous rise 
has been seen in case detection rate of childhood TB worldwide with a parallel increase 
in the death toll in children with TB. In 2014, 136,000 children died from TB 
worldwide and the rate increased significantly to 210,000 deaths in 2015. 
 
1.2 Childhood TB 
TB in children has traditionally been deserted by practitioners, researchers and 
expounders partially, with the notion that children are rarely infectious and therefore 
add little to the dissemination of disease. A confirmed diagnosis is often challenging 
in children because of a low bacillary load and difficulties in specimen collection. 
Thus, diagnosis of TB is repeatedly completed presumably on the basis of a 
combination of clinical symptoms (Marais et al., 2005) and radiological findings 
(Dodd et al., 2014). In addition to the diagnostic uncertainties, a major challenge for 
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estimating burden is under-reporting. The challenges of confirming diagnosis are more 
in less than 5 years age; additionally, this age group also has an increased risk of severe 
disease and TB-related mortality (Seddon et al., 2015). Because of the difficulty in 
diagnosis of TB in children and insufficient data recording, little accurate information 
regarding childhood TB is available from countries with a high TB incidence (Donald 
et al., 2007). 
Childhood TB is an indication for on-going transmission of TB within a 
community. Because the young children spent most of the time with their households, 
TB transmission is therefore supposed to be absolutely from adults in the household, 
particularly with smear positive adult cases (Kompala et al., 2013; Middelkoop et al., 
2014). Level of exposure and contact hours with TB case indicates the severity of 
infection (for instance interaction of an infant with mother or any other caregiver in 
the household). The risk of developing TB disease subsequent to infection is hence 
greater for children under 5 years of age (WHO, 2014). 
 
1.3 Diagnosis 
Diagnosis of PTB in children can be challenging due to radiological changes, 
difficulty of making a definitive microbiologic diagnosis and nonspecific signs and 
symptoms (Zar et al., 2015). These challenges create difficulties for understanding the 
risk factors for childhood TB and the poor outcomes from disease (Nelson and Wells, 
2004). Depending on local epidemiology, various algorithms and scoring systems have 
been developed to foresee TB in patients with negative sputum (Siddiqi et al., 2003). 
The scoring system is possibly a valuable diagnostic method of TB, particularly in 




The use of definite symptoms significantly improves diagnostic accuracy of 
PTB. It has been reported that presence of 3 symptoms at presentation can provide 
good diagnostic accuracy (sensitivity 82.3%, specificity 90.2%, positive predictive 
value 82.3%) in immune competent children ≥ 3 years of age, i.e. persistent non-
remitting cough more than 2 weeks, failure to thrive during the foregoing 3 months 
and fatigue (Marais et al., 2006b). 
Until recently, TST was the only commercially available immunologic test for 
diagnosis of LTBI (Bua et al., 2013) and is considered as standard method for detecting 
asymptomatic infection of MTB. A standard dose of 5 tuberculin units (TU) (0.1mL) 
is injected intradermal and the reaction is measured as millimetres (mm) of in duration 
after 48 to 72 hours. TST has low specificity as the antigen used for the test purified 
protein derivative, (PPD), is a mixture of more than 200 mycobacterial antigens also 
present in non-Tuberculous mycobacteria and in the BCG vaccine strains. 
CXR is of great significance in sputum and culture negative TB (Kaguthi et 
al., 2014) or inability of the patient to produce sputum (Bhalla et al., 2015). Despite 
its many limitations, the CXR remains the most practical and helpful test (Marais et 
al., 2006c) in abnormal findings among children with TB (Swingler et al., 2005). 
Microscopy is rapid, inexpensive and less labour intensive than other 
technologies. Detection of AFB using smear microscopy is the primary diagnostic 
method of TB in DOTS based programmes in low and middle income countries, 
(WHO, 2009a) providing results within hours. Culture is not performed in resource 
poor settings consistently but used for purposes of surveillance, treatment failure, or 
detection of drug resistance. 
In December 2010, Gene Xpert MTB/RIF (Xpert MTB/RIF) assay was 
endorsed by WHO and then recommended that it needs to be evaluated in childhood 
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TB (WHO, 2010c). The Xpert MTB/RIF assay is a rapid molecular assay that can be 
used by operators with minimal technical expertise, enabling diagnosis of TB and 
simultaneous assessment of RIF resistance to be completed within 2 hours (Lawn and 
Nicol, 2011). 
 
1.4 BCG vaccine 
BCG is a live attenuated vaccine derived from Mycobacterium bovis and has 
been given to children since the 1920s (Rekha and Swaminathan, 2007). The only 
licensed vaccine for the prevention of TB and leprosy is BCG. More than 100 million 
doses of BCG are given each year. It is accepted that BCG vaccine protects young 
children (< 5 years) against more dangerous forms of EPTB and thus, is given as a 
routine vaccination in many countries, as recommended by the WHO. Though the 
efficacy of BCG vaccine against PTB is doubtful (Beresford and Sadoff, 2010) and 
differs geographically. A meta-analysis on the efficacy of BCG vaccination in new 
born and infants in the prevention of TB demonstrated that BCG vaccine provided a 
protective effect of 71% against TB deaths and 64% against TB meningitis (Colditz et 
al., 1995). A further meta-analysis revealed a BCG protective effect of 86% against 
miliary or meningeal TB in randomized controlled trials and 75% in case- control 
studies (Rodrigues et al., 1993). In 2004, WHO recommended a single dose of BCG 
vaccine after birth in HBC, unless the child presented with symptomatic HIV infection 
(WHO, 2004a). This is because serious immunodeficiency states like AIDS are 
associated with increased incidence of local as well as systemic disseminated BCG 






1.5 Geography of Pakistan 
Pakistan is located in the Middle East near the Gulf of Oman and the Arabian 
Sea. It is the country with 6th number largest population in the world and the second 
largest Muslim population. The country is a developing nation with an underdeveloped 




1) Sindh: Land Area: 140,915 square kilometer, Population: 47,886,051.Rural: 
22,975,593, and Urban: 24,910,458. 
2) Balochistan: Land Area: 347,190 square kilometer, Population: 12,344,408, 
Rural: 8,943,532, and Urban: 3,400,876. 
3) Punjab: Land Area: 205,345 square kilometer, Population: 110,012,442, Rural: 
69,625,144, and Urban: 40,387,298, Islamabad is capital city of Pakistan which is 
considered a separate Federal administrative area rather than a province but its 
population was given separate in census report 2017. Total population: 2,006,572, 
Rural: 991,747, and Urban: 1,014,825. 
4) Khyber-Pakhtunkhwa (KPK): Land Area: 74,521 square kilometer, 
Population: 30,523,371, Rural: 24,793,737, Urban: 5,729,634. 
5) Federally Administered Tribal Areas (FATA): The tribal belt adjoining KPK 
northern territory of Pakistan managed by the Federal Government and   is   
named   Federally   Administered   Tribal   Areas.    Land Area: 72,971 square 






1.6 Health care system in Pakistan 
The health system in Pakistan is comprised of public and private sectors. 
Development of national policies and strategies for intact population comes under the 
major responsibility of Ministry of Health (MOH) at the Federal level. Apart from the 
federally administrated areas, health is first and foremost accountability of the 
provincial government under Pakistan constitution. Although Pakistan's health sector 
is basically a provincial subject, health care delivery is generally administered by the 
federal and provincial governments together with districts mainly responsible for 
implementation. There are 1,142 hospitals, 5,499 dispensaries, 5,438 basic health units 
(BHU) and 671 maternity and child health centres. A BHU is an extended framework 
consists of lady health visitor, mid-wives and communicable disease control. 
Immunization, family planning, providing experienced birth attendants in delivery, 
antenatal and post-natal care, nutritional counselling, management of reproductive 
tract infection and sexually transmitted infection comes under services of BHUs 
(Noureen, 2017). TB services are provided by chest clinics in tertiary (including public 
and private) district and sub-district hospitals, rural health centres and BHU (Fatima 
et al., 2014). 
 
1.7 National TB Control Program in Pakistan 
The National TB Control Program (NTP) was implemented in 1995 and after 
descending, it was revitalized in 2001 (Chughtai et al., 2013). The mission of NTP was 
to attain TB control at national level by Directly Observed Treatment, Short Course 
(DOTS) strategy and by certifying quality TB care through public sector health 
services together with private sector and Non-Governmental Organizations (NGOs) 
(NTP, 2004). In addition to this, major concern of NTP was to reduce the levels of 
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underreporting by: increased cooperation of public and private sector, obligatory 
notification of childhood TB cases and efforts to assemble data on diagnosed cases 
from amenities not consistently reporting to national surveillance systems. In Pakistan, 
health care is a liability of provincial government whereas the district presents health 
care services to urban and rural regions. In NTP, the TB control services in the district 
health system, operates in the course of diagnostic centres and treatment centres. 
The diagnostic centre diagnoses the TB case having its individual laboratory with a 
laboratory technician to carry out the sputum smear microscopy. A treatment centre is 
responsible to distribute the anti-tuberculosis treatment (ATT) to the patients. 
Furthermore, the treatment support is offered to the patients by a network of 
community health workers. The ATT are principally promoted by the NTP and 
supervised through district health authorities. Once the cases are registered, the 
quarterly reports on case findings and treatment outcomes are sent to the district TB 
coordinator office, who integrates these reports and pass on a quarterly consolidated 
district reports to the provincial TB control office. Regular quarterly intra and inter 
district meetings are held to fortify the reports to avoid errors and to further improve 
the program. 
NTP, working under the Ministry of National Health Services, Regulation & 
Coordination, is fighting against TB to lessen the mortality, morbidity and spread of 
TB infection in the country. NTP is incorporated with Primary Health Care system 
implemented by the district health authorities with the support of Provincial TB 
Control Programs (PTPs). The NTP is responsible for overall TB Control Activities in 
the country including Policy Guidelines, Technical Support, Coordination, 
Monitoring, Evaluation and Research whereas the PTPs and Districts are responsible 
for the actual care delivery processes including program planning, training of care 
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providers, case detection, case management, monitoring and supervision. Since 2001, 
over 2.1 million TB patients have been diagnosed and treated with quality assured free 
of cost ATT in both public and private sector across the country in the course of 1,500 
qualities assured microscopy and 5,000 treatment centres. Approximately 300,000 TB 
cases were notified to NTP and Treatment Success Rate remained at 91% during 2013 
(NTP, 2013). 
 
1.8 Directly observed treatment 
The Directly observed treatment (DOT), a critical aspect of the DOTS strategy, 
is an effort to improve adherence to TB treatment (Wright et al., 2015). DOTS 
supervisors encourage and supervise patients swallowing each and every dose of their 
anti-TB drugs during the treatment course (Wright et al., 2004). A DOTS supervisor 
can be a medical staff member, a family member, any health worker, a teacher, or any 
volunteer from community (Dick et al., 1996). Supervision of TB treatment through 
DOT at health clinics can put extra burden on health care systems, mainly in high TB 
burden and resource limited settings. Beside this, it is tiresome for patients to visit a 
health clinic daily for treatment supervision, in terms of traveling and waiting times 
(Wright et al., 2015). Community-based DOT is intended to reduce the strain of patient 
care on health facilities in high TB burden countries in terms of cost effectiveness and 
control over TB transmission (Nardell and Dharmadhikari, 2010). Family member as 
DOTS supervisor for TB patients has also proven as an efficient and cost effective 
technique in different studies (Maciel et al., 2008). Study conducted in Pakistan found 
no statistically significant difference in cure rate for DOTS with direct observation by 
health workers, DOTS with direct observation by family members and DOTS without 
direct observation (Khan et al., 2002). Similarly, a controlled trial in Nepal revealed 
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that family members are as proficient as health care staff in treatment administration 
(Newell et al., 2006). While evaluating the effectiveness of DOTS, treatment 
completion rates for the patients supervised by their family members was significant 
in contrast to the supervision by health professionals (Okanurak et al., 2007). Despite 
of these results, no conformity about the use of family members as treatment 
supervisors by TB control programs is endorsed in the TB guidelines. 
 
1.9 TB in Pakistan 
TB is an endemic and foremost public health problem in Pakistan. Despite its 
high prevalence in the country, it had been a deserted area in the past. TB control was 
nearly fictional in the country until the NTP was reinforced in 2001 (Vermund et al., 
2009). In 1962, the first TB survey in Pakistan led to foundation of collaborative efforts 
for TB control between MOH, WHO and United Nations International Children 
Emergency Fund (UNICEF). The main focus was set to develop specialized TB 
centres and wards at the district head quarter hospitals (DHQ). But, UNICEF departed 
in 1985 and pull out its financial support. In 1993, WHO announced TB as a global 
emergency and the Government of Pakistan administered the DOTS strategy to have 
the effective TB control. In 1994 the TB control policy, national policy and technical 
guidelines were revised by the MOH in collaboration with WHO. Later on, in 1996 
the Directorate for TB Control of Pakistan was eliminated and the Medical 
superintendent (MS) of the TB Centre was made responsible for NTP, with no any 
additional support. Accordingly, in 1998, Pakistan was stated as one of the 16 countries 
without an appropriate NTP (De Muynck et al., 2001). 
The primary features of TB epidemiology consist of socioeconomic 
dissimilarities, rapid urbanization and population growth at the global level. All these 
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features lead to lack of food, starvation, poor housing and socio-economic, geographic 
and cultural hurdles to approach the health care. Crowdedness in homes and localities 
raise the chances of exposure to TB infection, whereas poverty and scarcity of food 
may possibly enhance the vulnerability to TB infection (Hargreaves et al., 2011). 
People are moving from the rural to urban areas in search of better livings and access 
to rather better education and healthcare services, thus growing the number of people 
living in substandard housing called slums. The millions of people living in slums do 
not have access to the education and health services, affecting the children and females 
most. In urban areas, increased rate of death is reported in children ≤ 5 years of poorer 
as compared to rich people. Practically 8% of the global burden of deaths ˂ 5 children 
occurred in Pakistan due to insufficient nutrition and health care support (UNICEF, 
2016). Living conditions in many urban slums are worst. The bulk of people in areas 
with inadequate provision of water, sanitation, garbage collection and health care 
produce the conditions where infectious diseases can spread at greater rate. Infectious 
disease in Pakistan is thought to be correlated to the poor sanitation and unsafe potable 
water (WHO, 2007). 
Pakistan currently stands as 5th highest burden of TB together with the 4th 
highest burden of drug resistant TB globally and is one of the 6 countries that stand 
out as having the largest number of incident cases in 2014 (NTP, 2015; WHO, 2015). 
In 2016, of total estimated incidence of 518,000 TB cases notified in Pakistan, 51,000 
were cases of children aged ≤ 14 years (WHO, 2017). Pakistan is one of the 6 countries 
accounting 60% of new TB cases (WHO, 2016). Pakistan adds approximately 44% of 
TB burden in the Eastern Mediterranean Region and 5.1% of the total national disease 
burden is accounted with TB (Vermund et al., 2009). TB ranked as 6th of top 10 causes 
of motility in Pakistan (WHO, 2007). 
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There are many reasons why TB rates are still higher in Pakistan. In the absence 
of health insurance and social protection, it is hard for the poorest to access health 
services while they are sick. This contributes to undiagnosed TB, sustained 
transmission in the community and poor treatment outcomes in diagnosed TB cases. 
As definite connection between poverty and TB is previously reported (Oxlade and 
Murray, 2012), majority of TB cases are found in people with low income, mostly 
uneducated and limited resources. In Pakistan, malnutrition is common among all ages. 
According to the National Nutrition Survey 2011, one-third of all children are 
underweight because of existing poverty and food insecurity; not only increasing the 
risk of morbidity and infections but also impede the growth and mental development 
of a child. Beside this, poor are living in substandard overcrowded and poor ventilated 
houses and polluted communities, expected to boost the risk of TB transmission 
(Marais et al., 2009). 
 
1.10 Management of childhood TB in Pakistan 
1.10.1 Diagnosis of childhood TB 
Children with TB registered in five selected hospitals were diagnosed 
according to algorithm presented by NTP (Figure 1.1) and treated under the DOTS 
program where a paediatrician, i.e. child or TB specialist, DOTS facilitator, laboratory 
technician and field officer were working as a team for DOTS. The recording and 
reporting (R & R) of routine TB cases was the liability of a DOTS facilitator. Children 
presented to the hospitals with clinical symptoms including cough lasting for ≥ 2 
weeks, fever, night sweat, dyspnea, weight loss and sputum production were 
examined. TST was done using standard of 5 tuberculin units (TU in 0.1 mL), during 
the initial visit and read at 48-72 hours. Since children were being evaluated for TB, a 
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TST ≥ 10 mm was considered positive (WHO, 2014). Antero- posterior view was 
performed in all children. The CXR was read by a local paediatrician and a general 
physician. CXRs were evaluated for the presence and location of hilar 
lymphadenopathy, opacification (consolidation), nodular images, pleural effusion, 
cavitation, calcification or vertebral spondylitis. If at least one of the above features is 
found, the CXR was classified as persistent with TB. An abnormal CXR with 
symptoms suggestive of TB were referred for sputum microbiological examination 
including smear and Xpert MTB/RIF. In the absence of symptoms with an abnormal 
CXR a course of antibiotics was given and a repeat CXR was performed two weeks 
later to rule out persisting abnormality. Children with a normal CXR, but with 
persisting symptoms were evaluated for EPTB. Fluorescence microscopy was being 
used for sputum smear samples for the presence of AFB. In addition, Xpert MTB/RIF 
assay was routinely done in PTB- and PTB+ patients for further confirmation of MTB 
and drug resistance TB. For EPTB, diagnostic tests were performed depending on the 
sites involved. X-ray was done in all cases of EPTB so as to exclude the concomitant 
pulmonary involvement. Fine Needle Aspiration Cytology (FNAC) was the first-line 
diagnostic technique for the peripheral lymphnodes. However, if the FNAC 
examination results were indecisive, excision biopsy was done for definitive diagnosis. 
Fluid specimens (pleural, cerebrospinal fluid, gastric aspirate, synovial) were 
subjected to microscopy, culture, Xpert MTB/RIF and biochemical analysis. 
Diagnosis of skin TB was more complex and hence multiple tests were performed to 
ascertain the diagnosis including microscopy, tissue culture and skin biopsy with 
histological analysis. For children who cannot expel sputum, the diagnosis was 




Table 1.1 shows the NTP and PPA scoring chart for screening of TB in children 
used as diagnostic algorithm during the study as per recommendations of NTP (NTP, 
2006). Patients with PPA score ≥ 5 were suggestive of TB contrary to the NTP where 
PPA score ≥ 7 is standard (NTP, 2015). Children who were diagnosed with TB disease 
were initiated on ATT. At the end of treatment, outcomes were recorded as per WHO 
criteria. Patients who were stated “cured” and/or “completed treatment” were recorded 
as “treatment success”, and all those patients who were defaulted, died, or practiced 
treatment failure were reported under category of “unsuccessful treatment”. A cured 
patient was a bacteriologically confirmed PTB patient and became smear negative in 
the last month of treatment and on at least one previous occasion. Treatment completed 
included TB patients who completed treatment with no record to show smear negative 
in the last month of treatment and on at least one previous occasion (WHO, 2014). 
Table 1.1: NTP and PPA scoring chart for screening of TB in children at DOTS centers 
in Pakistan. 
Condition Scores* 
1 2 3 4 5 
Age < 2 years     
Close contact in 
last 2 years 
PTB- patient  PTB+patient   
BCG scar Absent     
Low immune 
status 
Yes     









CXR Non-specific Suggest 
TB 
   
TST 5-10 mm  >10 mm   
Granuloma Non-specific    TB 
History of measles 
and whooping 
cough 
3-6 months <3 months    





















Negative TST does not rule out TB, evaluate further if strongly suspected. **prolong illness like cough, fever, weight loss, abdominal mass, 
lymphadenopathy etc., and history of contact with TB case in family. ***Absence of above.  
 




Administer PPD If child is seriously ill, refer to tertiary center 
Positive: If TST ≥10 mm *Negative: If TST < 10 mm 
CXR, Sputum smear/Gastric lavage for AFB, PPA scoring **TB Strongly suspected ***Not strongly suspected 
AFB sputum smear positive Gastric aspirate 
positive 
CXR suggestive PPA score 
> 7 
CXR suggestive PPA score 
< 7 
Declare TB and register as TB patient Give antibiotics and examine after 7-10 days 




1.10.2 Treatment of children with TB 
All PTB and EPTB cases were treated with the same standardized first-line 
anti-TB regimen. Treatment was free and was only provided by the DOTS program 
for all TB patients. The treatment of all new TB cases (Category-I, with no previous 
history of TB treatment) was comprised of INH, RIF, and PZA for 2 months intensive 
phase followed by INH and RIF for 4 months continuation phase. For category-II 
patients (relapse, failure and default), INH, RIF, PZA and EMB were given for 3 
months intensive phase and INH and RIF during 5 months continuation phase. Based 
on the pre-treatment weight, children were assigned to one of 4 pre- treatment weight 
bands (5 to 7 kg, 8 to 14 kg, 15 to 20 kg and 21 to 30 kg). They were treated on the 
basis of pre-fixed weight band dosage. Patients weighing less than 5 kg were treated 
with individualized dosages while those weighing more than 30 kg were treated using 
adult dosages. As improvement in weight was observed during monthly visits, dose of 
ATT was then adjusted accordingly. During follow- up, sputum microscopy was 
performed for PTB+ and PTB- patients and those with EPTB and no sputum 
examination (PTBNS) were monitored clinically. 
 
1.11 Sindh province 
Sindh is the 2nd largest populated province of Pakistan located at west corner 
of South Asia. Geographically, Sindh is 3rd largest province of Pakistan, about 579 km 
from north to south and 281 km from east to west, with an area of 140,915 square km 
(54,408 square miles) of Pakistani territory. Generally, Sindh is known as the lower 
valley of Indus (Encyclopedia, 2017). There are 3 well defined parts of Sindh: The 
Siro (Head), The vicholo (Middle) and The Lar (Descent). Locally, Sindh, province is 




Karachi, Pakistan's largest city and financial hub, is provincial capital of this province. 
Sindh is divided into 6 divisions and 29 districts. Hyderabad division has total 9 
districts including Hyderabad, Jamshoro and Matiari. 
In 2010, the Sindh province had an estimated population of 42.4 million people 
with approximately equal rural (51.2%) and urban (48.8%) natives (Khan, 2017). 
Sindh is a multicultural province of Pakistan and is portrayed by an extensive gap 
between rich and destitute individuals with unequal access to health services. 
Inhabitants of low-wage neighbourhoods, for instance, suffer from overcrowding and 
malnutrition. Consequently, they are susceptible to developing TB (Akhtar et al., 
2007). The uncertain NTP framework frequently brings about confusions and false 
beliefs among TB patients in Pakistan, particularly in rural zones of Sindh. These 
myths have transformed TB into a social shame. This defamation negatively affects 
patients and makes them uncertain to look for treatment. Extremely restricted learning 
about Bacillus Calmette-Guerin (BCG) as a preventive measure against TB has been 
accounted for among provincial occupants in Sindh. Be that as it may, a significant 
number of rural populations had little information of how to secure against TB (Khan, 
2017). 
 
1.12 Problem statement 
To restraint childhood TB in Pakistan, NTP developed its guidelines in 2006 
to 2007 in collaboration with the Pakistan Paediatric Association (PPA). The 
guidelines included the protocols with a principle to get better care of children with 
TB (NTP, 2006). Nevertheless, the program has met with considerable success; 
Pakistan is however far-off from attaining its target. It is prerequisite to give enough 




executed in Pakistan. TB is treated with a multi-drug regimen, and is thus 
exceptionally vulnerable to incidences of adverse effects, unacceptable patient 
compliance and slow improvement of patients (Prabakaran et al., 2004). The reporting 
of ADRs is still frequently disregarded by medical professionals and has yet not 
grasped the meriting significance in Pakistan (Khan et al., 2015b). It is realized that 
making mindfulness on the significance of ADRs monitoring is a confirmation for 
setting up and maintaining a thorough ADRs reporting system (Iffat et al., 2014). The 
duration and complexity of treatment result in non-adherence to treatment. This leads 
to suboptimal response (failure and relapse), the emergence of resistance and 
continuous spread of the disease. TB patients who are non-adherent or not cured are 
the common scourge not only for individuals and community, but pose a challenge to 
effective TB control as well (Tesfahuneygn et al., 2015). In high burden countries 
(HBC) like Pakistan, ensuring treatment adherence and reaching a high treatment 
success rate hence regularly gets less consideration (D‟Souzaa et al., 2017). WHO has 
developed DOTS strategy to optimize response and adherence to TB treatment (Van 
den Boogaard et al., 2009). Monitoring the outcome of treatment is essential in order 
to evaluate the effectiveness of the DOTS program. Furthermore, understanding the 
specific reasons for unsuccessful outcomes is important in order to improve treatment 
systems (Vasankari et al., 2007; WHO, 2009b). 
As per WHO recommendations, children must be considered as infectious if 
they are sputum smear positive or have cavitation on chest X-ray (CXR). When the 
index case is a child, it is recommended that contact screening should be done to 
pinpoint the source case (WHO, 2014). Contact investigation is an approach to identify 
active disease or Latent Tuberculosis infection (LTBI) among the contacts of known 




In Pakistan, the increased risk of TB may be associated with highest proportion 
of poverty. Poor people are malnourished, living in overcrowded houses and mostly 
remain uneducated due to lack of resources (Figure 1.2) (Khan, 2017). Research 
contribution in childhood TB is still limited and only few studies have been conducted 
until now. Beside this, little is known in regard to the epidemiology, clinical outcome 
and adherence to ATT of the childhood TB. This study aimed to contribute to 
childhood TB management by investigating whether certain factors are associated with 
TB and poor treatment outcomes among children living in a developing country. It is 
worth mentioning that no study has been conducted to estimate the incidence and risk 
factors of TB among children, measure the treatment outcomes, assess and manage the 
adverse drug reactions (ADRs), determine risk factors for unsuccessful treatment 
outcome and incidence of ADRs, approximate the knowledge of adherence to ATT 
among the caregivers and evaluate contact screening among the household contacts 
(HHC) of TB children. 
 
Figure 1.2: Relationship of poverty and TB. 
Poor community 
Lack of basic health services, 
nutrition and inadequate living 
conditions 
Longer delay 
between disease and 
cure 












In general, the objective of the present study was to evaluate the proportion, 
management and treatment outcomes of children with TB in 3 districts (Hyderabad, 
Jamshoro and Matiari) of Sindh province, Pakistan. Due to the available resources, 
time and access limitations, the above said districts of Sindh province were focused in 
the present study. 
 
1.14 Specific aims 
The definite aims of the present study were to evaluate: 
i. Socio-demographic and clinical characteristics of children with TB. 
ii. Rate and predictors of delayed sputum conversion. 
iii. Treatment outcomes and risk factors of unsuccessful treatment outcomes of TB 
regimen. 
iv. Occurrence of ADRs in study population, using causality  assessment scale 
(Naranjo) and severity assessment scale (Hartwig and Siegel), and their 
possible impact on ATT. 
v. Treatment adherence among the caregivers of children under ATT using the 
Morisky Green Levine Medication Adherence Scale (MGLS-U) and Visual 
Analogue Scale (VAS). 
vi. Contact screening among the HHC of TB children and risk factors of TB 
among the HHC. 
 
1.15 Significance of study 
 
Despite the increased global attention, findings and achievements in the control 




from the advances in diagnosis and treatment. TB transmission to children not only 
indicates inadequate control in the community, but creates a pool of latently infected 
individuals who form the source of adult disease at some time in the future. Therefore, 
early detection of childhood cases is important in order to prevent further 
dissemination of TB in future. Data regarding childhood cases in Pakistan is scarce. 
This is the first study conducted in 3 districts (Hyderabad, Jamshoro and Matiari) of 
Sindh province of Pakistan. The current study will help pharmacists, clinicians and 
program managers to: 
i. Reduce TB infection by controlling risk factors of TB. 
ii. Increase in treatment success rate by looking into the predictors of 
unsuccessful treatment outcomes. 
iii. Minimize noncompliance after giving knowledge regarding expected ADRs 
and their management. 
iv. Improve treatment outcomes by educating the caregivers for adherence of 
ATT and assessing factors for non-adherence. 
v. Decrease morbidity and mortality by early detection of TB cases among HHC 







2.1 Epidemiology of childhood TB 
TB remains a disease of poor, over-burdened and vulnerable populations. 
Despite of effective treatment regimens, lack of proper diagnosis, non-adherent to 
treatment and barriers to infection control keep the constant transmission of TB. 
Globally, nearly one million children were affected with TB in 2015, accounted for 
6.9% of the new cases notified in 2016 (WHO, 2017). Annually, 75% of total 
childhood TB cases are reported in 22 HBC, where they comprise 20 to 40% of total 
TB (Swaminathan and Rekha, 2010). 
 
2.2 Prevalence and incidence of childhood TB 
According to National Institute of Mental Health, “Prevalence” is the 
proportion of a population who have a specific illness, a condition or a risk factor in a 
given time period, usually expressed as a percentage or as the number of cases per 
10,000 or 100,000 populations while “Incidence” is a measure of the number of new 
cases of an illness, a condition or a risk factor that occur in a population over a given 
period. Prevalence studies are done to evaluate the burden of disease in a population, 
to compare the frequency of disease in different populations and to study the trends of 
severity of disease over time (NIH, 2017). 
A National surveillance study in England and Wales was conducted between 
1999 and 2006 to estimate the incidence of TB in children younger than 16 years. 
Around 3,563 cases of TB were reported in children, giving an incidence rate of 
4.3/100,000 in general. The highest incidence rate was found in 15 years old age group 




3.2/100,000 population. Beside this, black African and those born outside United 
Kingdom (UK) had the highest incidence rate of TB (87.6/100,000 and 37.3/100,000) 
comparatively to white population and those who were born in the UK (1.1/100,000 
and 2.5/100,000). However, maximum numbers of cases were estimated from India, 
Pakistan, Philippines, Somalia, and Zimbabwe (Abubakar et al., 2008). 
Menzies et al., (2010) retrospectively evaluated the incidence rate of TB 
among United States of America (USA) and foreign born children (less than 13 years) 
and adolescents (13 to 17 years) from 1994 to 2007. About 8% of total cases were 
reported for children and adolescents. Study findings suggested the highest TB rates 
for both USA and foreign born children younger than 5 years. TB rates declined from 
2.1/100,000 population in 1994 to 1.1/100,000 in 2007 among USA born children and 
adolescents and also for foreign born children from 20.3/100,000 to 11.4/100,000 
population. The number of TB cases among foreign born children and adolescents was 
highest in the starting year of study and finally declined to 33% in 2007. During the 
study, more or less 90% of children and adolescents completed treatment successfully. 
The incidence rate of TB among the children under 16 years was calculated 
from 1998 to 2009 in Oslo. The overall incidence rate of TB among all children was 
2.6/100,000 population per year. For non-Western and those from Somalia, the overall 
incidence rate was 8.1/100,000 and 52.5/100,000 population. PTB, hilar 
lymphadenopathy and cases of lymph node TB were most frequently seen during the 
study period. From 19 of culture positive cases, 1 patient was reported resistant to 
streptomycin (SM), 2 to isoniazid (INH) and 2 were found resistant to both INH and 






Moyo et al., (2010) conducted a retrospective study between 1999 and 2004 in 
Cape Town, South Africa to estimate the incidence and severity of TB in children less 
than 5 years old. Children aged ≤ 11 months had highest proportion of bacteriological 
confirmed TB cases. The incidence rate in this group of age was notified as 0.2%. The 
highest rate of incidence (1.2%) was reported in children aged 12 to 23 months. The 
cumulative incidence of definite and probable TB was 2.9% in children less than 5 
years and those aged 12 to 35 months had the highest incidence rate of severe TB. 
Another retrospective study conducted in Kilimanjaro region assessed the 
incidence of childhood TB and treatment outcomes for the period 2002 to 2006. During 
this time, detection rate was 147/100,000 for urban and 41.8/100,000 for rural 
populations, thereby constituting 13% of total TB burden. Around 75.2% had PTB; 
5.8% of patients tested for AFB were sputum positive (PTB+). The remaining 94.2% 
were presumptively treated for TB. Treatment success rate was 79.9% with 10.9% of 
mortality and 7% of default rate. The proportion of childhood TB was presented as 
13.9, 12.4 13.1, 11 and 13.6%, respectively from 2002 to 2006. The prevalence of 
childhood TB during the study time frame ranged from 41 to 59/100,000 population 
per year, at the average of 52.8/100,000 (Mtabho et al., 2010). Hatleberg and his 
colleagues (2014) retrospectively illustrated the trends of epidemiology and treatment 
outcomes of TB among children aged less than 15 years in Denmark from 2000 to 
2009. Nearly half of the cases were presented from ≤ 4 years and 10 to 14 years in 
Danes and immigrants. Resistance to any drug was found in 18 of 159 cases, tested 
for drug susceptibility. Thirteen children were presented with mono-resistant to INH, 
2 with ethambutol (EMB) and 2 with pyrazinamide (PZA) mono-resistant. However, 
1 case was found to be MDR-TB with resistant to rifampicin (RIF), INH and EMB. 




Danish children during the study time. Conversely, the trend of TB for immigrant 
decreased from 94.1/100,000 to 35.1/100,000 during the same time. 
To estimate the incidence of childhood TB in 22 HBC (Afghanistan, 
Bangladesh, Brazil, Burma, Cambodia, China, DR Congo, Ethiopia, India, Indonesia, 
Kenya, Mozambique, Nigeria, Pakistan, Phillipines, Russia, South Africa, Thailand, 
Uganda, Tanzania, Vietnam, Zimbabwe) for the year 2010, a mathematical model 
study was conducted by Dodd et al., (2014) for children younger than 15 years. During 
the study year, almost 7,600,000 children became infected with MTB whereas 650,000 
developed TB. However, calculated proportion of total TB burden in children for each 
country varied from 4 to 21%. In all children notified with TB, 14% of the cases were 
likely to be of EPTB. 
Wobudeya et al., (2015) conducted a retrospective study in Kampala, Uganda 
to estimate the incidence of TB in children aged under 15 years during 2009 to 2010. 
Around 7.5% of all registered cases were presented with cases of childhood TB. Of 
these, half of the cases were accounted for children less than 4 years, 25% of cases 
were 10 to 14 years and 5 to 9 years represented 21% of the cases. Nearly 89% of the 
children had PTB; with 15% PTB+ and 11% had EPTB. The incidence of childhood 
TB in Kampala was 56/100,000 and 44/100,000 in 2009 and 2010, respectively. 
In Pakistan, a retrospective study was carried out for children aged < 15 years 
treated under the NTP in public hospitals of 3 districts of Punjab province. Of total 
920 child TB cases, only 189 were notified during 2004 to 2005, almost 3 times less 
than those reported in 2006 to 2007. The implementation of policy guidelines for 
childhood TB resulted in increased annual notification rate of childhood TB cases from 
1.4/100,000 in 2004 to 2005 to 5.2/100,000 population in 2006 to 2007. About 66.3% 




uncategorized. Fifty-five cases of total PTB were found as PTB+ (Safdar et al., 2010). 
 
2.3 Sputum smear conversion during TB treatment and predictors of 
sputum non-conversion 
 
Sputum conversion is worthwhile in monitoring the TB program performance 
and as an indicator for assessing the patients who remain smear positive (WHO, 
2010a). Beside this, sputum smear conversion plays a vital role in monitoring the 
response to treatment of infectious cases of PTB (WHO, 2004b). The sputum 
conversion rate (SCR) is the percentage of PTB+ cases converted to smear negative 
(PTB-) after 2 months of treatment (Kayigamba et al., 2012). Patients are expressed 
as non-infectious once the sputum smear turned into negative. The intensive phase is 
extended to additional 1 month for the patient who remains smear positive at the end 
of 2nd month of treatment (Banu et al., 2007). If PTB+ patients do not become negative 
at the end of 5th month of ATT, treatment failure is declared in these patients (Azarkar 
et al., 2016). It is estimated that 80 to 90% of PTB+ patients experience smear 
conversion in 2 to 3 months of treatment. Negative smears during and at the end of 
treatment are requisite to state a patient cured of TB (WHO, 2004b). Consistent sputum 
smear at the end of the intensive phase of treatment is likely to be associated with 
unfavourable outcomes, definitely with failure and default and drug resistance TB. 
Below are given the findings of studies estimating sputum conversion rate and 
predictors of delayed sputum smear conversion and its effect on outcomes among TB 
adults. 
Kayigamba et al., (2012) conducted a study in Rwanda to evaluate the 
completion rate of sputum smear examinations at the end of the intensive phase of 
ATT and to calculate the sputum conversion rate. Smear examination at 2nd month was 
done in 1,039 out of 1,299 PTB+ patients. Among these, 82% turned into smear 
